Ferguson Wellman Capital Management, Inc is an investment advisory firm founded in 1975 with the focus of providing personalized services to clients. The firm is independent and employee-owned and fully dedicated to investment management. On November 4, 2014, the company submitted its SEC 13F Filings for the period ended September 30, 2014. According to the filings, Ferguson Wellman Capital Management, Inc, top three investments are Gilead Sciences, Inc. (NASDAQ:GILD), Apple Inc. (NASDAQ:AAPL), and Foot Locker, Inc. (NYSE:FL).
Gilead Sciences, Inc. (NASDAQ:GILD) emerged as the topmost investment of Ferguson Wellman Capital Management, Inc, with investment totaling $52.4 million. Gilead Sciences, Inc. (NASDAQ:GILD) is a research based biopharmaceutical company that researches, discovers, develops, and sells medicines across the globe. The company has focused on HIV/Aids, liver diseases, and a couple other conditions. Gilead Sciences, Inc. (NASDAQ:GILD) recently had its one-pill a day Hepatitis C drug dubbed Harvoni approved by the FDA.
Apple Inc. (NASDAQ:AAPL) came forth as the second largest investment of the firm, accounting for a total of $50.8 million in investment value. Apple Inc. (NASDAQ:AAPL) the designer, manufacturer, and seller of high end gadgets such as iPhones, iPads, iMacs, among several other devices. The company is set to produce several watches as it seeks to make forays into the wearable market. Apple Inc. (NASDAQ:AAPL) has recently ordered several chips to start the production of its highly publicized iWatch.
Foot Locker, Inc. (NYSE:FL) was the third biggest investment of Ferguson Wellman Capital Management, Inc, representing $46.9 million in investment value. Foot Locker, Inc. (NYSE:FL) is a sportswear and footwear retailer with its headquarters in New York City. The company sells high quality designer sneakers and apparel. The stock was recently upgraded to positive rating by a report released last Friday. Foot Locker, Inc. (NYSE:FL) performed well in its second quarter results, beating Thimson Reuters consensus projections. Other analysts at FBR Capital Markets have also given the stock a “market perform” rating. The company’s top institutional shareholders include Vanguard Group, Inc., Harris Associates L.P., and Fidelity Management and Research Company.
This article has been written by Victor Ochieng.